Literature DB >> 18180351

Mechanisms of resistance to daptomycin in Enterococcus faecium.

Clemente I Montero1, Frida Stock, Patrick R Murray.   

Abstract

In this study, we investigated the clonal emergence of daptomycin-resistant Enterococcus faecium strains isolated from a patient with leukocyte adhesion deficiency syndrome. The resistance mechanism in these strains is independent of either equivalent point mutations previously described for Staphylococcus aureus or daptomycin inactivation mechanisms identified in soil bacteria.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18180351      PMCID: PMC2258551          DOI: 10.1128/AAC.00774-07

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  25 in total

Review 1.  Antibiotic-resistant enterococci: the mechanisms and dynamics of drug introduction and resistance.

Authors:  Brett D Shepard; Michael S Gilmore
Journal:  Microbes Infect       Date:  2002-02       Impact factor: 2.700

2.  Emergence of daptomycin resistance in Enterococcus faecium during daptomycin therapy.

Authors:  James S Lewis; Aaron Owens; Jose Cadena; Kathryn Sabol; Jan E Patterson; James H Jorgensen
Journal:  Antimicrob Agents Chemother       Date:  2005-04       Impact factor: 5.191

Review 3.  Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing.

Authors:  F C Tenover; R D Arbeit; R V Goering; P A Mickelsen; B E Murray; D H Persing; B Swaminathan
Journal:  J Clin Microbiol       Date:  1995-09       Impact factor: 5.948

4.  Identification of chromosomal mobile element conferring high-level vancomycin resistance in Enterococcus faecium.

Authors:  S Handwerger; J Skoble
Journal:  Antimicrob Agents Chemother       Date:  1995-11       Impact factor: 5.191

5.  Daptomycin-resistant, methicillin-resistant Staphylococcus aureus bacteremia.

Authors:  A Mangili; I Bica; D R Snydman; D H Hamer
Journal:  Clin Infect Dis       Date:  2005-02-17       Impact factor: 9.079

6.  Enzymatic and chemical modifications of lipopeptide antibiotic A21978C: the synthesis and evaluation of daptomycin (LY146032).

Authors:  M Debono; B J Abbott; R M Molloy; D S Fukuda; A H Hunt; V M Daupert; F T Counter; J L Ott; C B Carrell; L C Howard
Journal:  J Antibiot (Tokyo)       Date:  1988-08       Impact factor: 2.649

7.  Detection of the van alphabet and identification of enterococci and staphylococci at the species level by multiplex PCR.

Authors:  Florence Depardieu; Bruno Perichon; Patrice Courvalin
Journal:  J Clin Microbiol       Date:  2004-12       Impact factor: 5.948

8.  Structural transitions as determinants of the action of the calcium-dependent antibiotic daptomycin.

Authors:  David Jung; Annett Rozek; Mark Okon; Robert E W Hancock
Journal:  Chem Biol       Date:  2004-07

9.  DNA fingerprinting of Enterococcus faecium by pulsed-field gel electrophoresis may be a useful epidemiologic tool.

Authors:  A G Miranda; K V Singh; B E Murray
Journal:  J Clin Microbiol       Date:  1991-12       Impact factor: 5.948

Review 10.  Perspectives on Daptomycin resistance, with emphasis on resistance in Staphylococcus aureus.

Authors:  Helen W Boucher; George Sakoulas
Journal:  Clin Infect Dis       Date:  2007-08-01       Impact factor: 9.079

View more
  14 in total

Review 1.  Daptomycin, a bacterial lipopeptide synthesized by a nonribosomal machinery.

Authors:  Lars Robbel; Mohamed A Marahiel
Journal:  J Biol Chem       Date:  2010-06-03       Impact factor: 5.157

Review 2.  Pathogenicity of Enterococci.

Authors:  Elizabeth Fiore; Daria Van Tyne; Michael S Gilmore
Journal:  Microbiol Spectr       Date:  2019-07

3.  Ampicillin enhances daptomycin- and cationic host defense peptide-mediated killing of ampicillin- and vancomycin-resistant Enterococcus faecium.

Authors:  George Sakoulas; Arnold S Bayer; Joseph Pogliano; Brian T Tsuji; Soo-Jin Yang; Nagendra N Mishra; Victor Nizet; Michael R Yeaman; Pamela A Moise
Journal:  Antimicrob Agents Chemother       Date:  2011-11-28       Impact factor: 5.191

4.  Emergence of daptomycin-resistant VRE: experience of a single institution.

Authors:  Mini Kamboj; Nina Cohen; Kathleen Gilhuley; N Esther Babady; Susan K Seo; Kent A Sepkowitz
Journal:  Infect Control Hosp Epidemiol       Date:  2011-04       Impact factor: 3.254

5.  Genetic basis for daptomycin resistance in enterococci.

Authors:  Kelli L Palmer; Anu Daniel; Crystal Hardy; Jared Silverman; Michael S Gilmore
Journal:  Antimicrob Agents Chemother       Date:  2011-04-18       Impact factor: 5.191

6.  Characterizing vancomycin-resistant Enterococcus strains with various mechanisms of daptomycin resistance developed in an in vitro pharmacokinetic/pharmacodynamic model.

Authors:  Molly E Steed; Celine Vidaillac; Warren E Rose; Patricia Winterfield; Glenn W Kaatz; Michael J Rybak
Journal:  Antimicrob Agents Chemother       Date:  2011-07-25       Impact factor: 5.191

7.  Pyrosequencing-based comparative genome analysis of the nosocomial pathogen Enterococcus faecium and identification of a large transferable pathogenicity island.

Authors:  Willem van Schaik; Janetta Top; David R Riley; Jos Boekhorst; Joyce E P Vrijenhoek; Claudia M E Schapendonk; Antoni P A Hendrickx; Isaäc J Nijman; Marc J M Bonten; Hervé Tettelin; Rob J L Willems
Journal:  BMC Genomics       Date:  2010-04-14       Impact factor: 3.969

8.  Life-threatening infection caused by daptomycin-resistant Corynebacterium jeikeium in a neutropenic patient.

Authors:  Christoph Schoen; Christian Unzicker; Gernot Stuhler; Johannes Elias; Hermann Einsele; Götz Ulrich Grigoleit; Marianne Abele-Horn; Stephan Mielke
Journal:  J Clin Microbiol       Date:  2009-05-06       Impact factor: 5.948

9.  Rapid emergence of daptomycin resistance in clinical isolates of Corynebacterium striatum… a cautionary tale.

Authors:  E McElvania TeKippe; B S Thomas; G A Ewald; S J Lawrence; C-A D Burnham
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-06-28       Impact factor: 3.267

10.  Daptomycin nonsusceptible enterococci: an emerging challenge for clinicians.

Authors:  Theodoros Kelesidis; Romney Humphries; Daniel Z Uslan; David A Pegues
Journal:  Clin Infect Dis       Date:  2011-01-15       Impact factor: 20.999

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.